These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 822973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases.
    McFarlane IG, Wojcicka BM, Tsantoulas DC, Portmann BC, Eddleston AL, Williams R.
    Gastroenterology; 1979 Jun; 76(6):1333-40. PubMed ID: 437430
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T, Gerken G, Meyer Zum Büschenfelde KH, Mayet WJ.
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [Abstract] [Full Text] [Related]

  • 5. Cell-mediated immune reactivity in liver disease.
    Bacon PA, Berry H, Bown R.
    Gut; 1972 Jun; 13(6):427-9. PubMed ID: 4557305
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
    Reynoso-Paz S, Leung PS, Van De Water J, Tanaka A, Munoz S, Bass N, Lindor K, Donald PJ, Coppel RL, Ansari AA, Gershwin ME.
    Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
    [Abstract] [Full Text] [Related]

  • 10. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
    Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H, Kaplan M, Gershwin ME.
    J Immunol; 1991 Jan 01; 146(1):89-94. PubMed ID: 1984455
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cell-mediated immunity to human Tamm-Horsfall glycoprotein in autoimmune liver disease with renal tubular acidosis.
    Tsantoulas DC, McFarlane IG, Portmann B, Eddleston AL, Williams R.
    Br Med J; 1974 Nov 30; 4(5943):491-4. PubMed ID: 4611578
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.
    Bernstein RM, Neuberger JM, Bunn CC, Callender ME, Hughes GR, Williams R.
    Clin Exp Immunol; 1984 Mar 30; 55(3):553-60. PubMed ID: 6368058
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Does the immune response play a role in the pathogenesis of chronic liver disease?
    Mondelli MU, Manns M, Ferrari C.
    Arch Pathol Lab Med; 1988 May 30; 112(5):489-97. PubMed ID: 3282484
    [Abstract] [Full Text] [Related]

  • 20. Migration inhibition studies in human disease.
    Brostoff J.
    Proc R Soc Med; 1970 Sep 30; 63(9):905-6. PubMed ID: 5536331
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.